Review: Yorkshire Voices by Grassington Players
WHAT a delightful evening we had at Grassington Players ‘Yorkshire Voices’. We were regaled with some first class entertainment written by the…
Source: cravenherald.co.uk
📰 Mark Bamforth News
Page 3 - Mark Bamforth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Bamforth. Real-time updates on events, politics, business and more.
Deals of the week January 31 to February 4 – a GrowthBusiness roundup
Deals of the Week, Jan 31-Feb 4. This week's VC deals include sustainable activewear brand Tala getting sweaty with a £4m investment.
Source: growthbusiness.co.uk
Cytiva To provide Arranta Bio 'Idea To Injection' solutions For integrated Manufacturing Of mRNA Products
Cytiva, a global life sciences leader, will provide its FlexFactory single-use manufacturing platform to Arranta Bio ("Arranta"), a leading...
Source: pharmaceuticalonline.com
TRADING UPDATES: BP signs biofuel deal; Elixirr expects revenue beat
TRADING UPDATES: BP signs biofuel deal; Elixirr expects revenue beat | Financial News
Source: lse.co.uk
Tern portfolio company Talking Medicines fund raise - DirectorsTalk Interviews
Tern portfolio company Talking Medicines fund raise
Source: directorstalkinterviews.com
Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)
/PRNewswire/ -- Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral...
Source: prnewswire.com
Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)
/PRNewswire/ -- Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral...
Source: prnewswire.com
Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)
ST ANDREWS, Scotland, Jan. 19, 2022 /PRNewswire/ -- Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral
Source: finanznachrichten.de
Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing
Share this article Share this article WATERTOWN, Mass., March 8, 2021 /PRNewswire/ -- Arranta Bio ("Arranta"), the leading microbiome contract development and manufacturing organization (CDMO), today announced the addition of a 130,000-square-foot facility in Boxborough, Massachusetts, to complement its existing facilities in Watertown, Massachusetts and Gainesville, Florida, bringing the total manufacturing capacity at Arranta to over 230,000 square feet. Arranta closed an oversubscribed Serie...
Source: prnewswire.com
DPS Group Global: DPS and TRIA Complete First Phase for Arranta Bio's Manufacturing Facility
DPS Group Global: DPS and TRIA Complete First Phase for Arranta Bios Manufacturing Facility BOSTON, MA / ACCESSWIRE / December 15, 2020 / DPS Group , a privately-owned, global engineering, procurement, construction management, and validation (EPCMV) firm serving high-tech process industries, and TRIA, a principal-led architecture firm with a focus on designing unique spaces for science, technology, and corporate clients, are pleased to announce the completion of the first phase of the 80,000 SF...
Source: finanznachrichten.de